These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16003667)

  • 1. Predictors of prescriptions for management of fatigue among veterans with multiple sclerosis.
    Hatzakis M; Turner AP; Williams RM; Bowen JD; Rodriquez AA; Haselkorn JK
    Arch Phys Med Rehabil; 2005 Jul; 86(7):1376-80. PubMed ID: 16003667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment.
    Dunmore FR
    Adv NPs PAs; 2013 Apr; 4(4):23-5, 32. PubMed ID: 23599993
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans.
    Vollmer TL; Hadjimichael O; Preiningerova J; Ni W; Buenconsejo J
    J Rehabil Res Dev; 2002; 39(2):163-74. PubMed ID: 12051461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services.
    Turner AP; Kivlahan DR; Kazis LE; Haselkorn JK
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1394-9. PubMed ID: 17964878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.
    Culpepper WJ; Wallin MT; Magder LS; Perencevich E; Royal W; Bradham DD; Cutter G; Bever CT
    J Rehabil Res Dev; 2015; 52(3):263-72. PubMed ID: 26220064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating fatigue in patients with MS: one step forward, one step back.
    Schwid SR; Murray TJ
    Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk of Chronic Multisymptom Illness in Spouses of Gulf War Era Veterans.
    Blanchard M; Toomey R; Karlinsky J; Reda D; Alpern R; Xue L
    Mil Med; 2017 May; 182(5):e1648-e1656. PubMed ID: 29087907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol misuse and multiple sclerosis.
    Turner AP; Hawkins EJ; Haselkorn JK; Kivlahan DR
    Arch Phys Med Rehabil; 2009 May; 90(5):842-8. PubMed ID: 19406306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating fatigue.
    Lapierre Y; Hum S
    Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderators of Treatment Outcomes After Telehealth Self-Management and Education in Adults With Multiple Sclerosis: A Secondary Analysis of a Randomized Controlled Trial.
    Ehde DM; Arewasikporn A; Alschuler KN; Hughes AJ; Turner AP
    Arch Phys Med Rehabil; 2018 Jul; 99(7):1265-1272. PubMed ID: 29337024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Suboptimal Medication Adherence in Persons With Multiple Sclerosis: Development of an Electronic Health Record-Based Explanatory Model for Disease-Modifying Therapy Use.
    Gromisch ES; Turner AP; Leipertz SL; Beauvais J; Haselkorn JK
    Arch Phys Med Rehabil; 2020 May; 101(5):807-814. PubMed ID: 31809751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS).
    Benito-León J; Martínez-Martín P; Frades B; Martínez-Ginés ML; de Andrés C; Meca-Lallana JE; Antigüedad AR; Huete-Antón B; Rodríguez-García E; Ruiz-Martínez J
    Mult Scler; 2007 Jun; 13(5):645-51. PubMed ID: 17548445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life.
    Turner AP; Kivlahan DR; Haselkorn JK
    Arch Phys Med Rehabil; 2009 Mar; 90(3):420-8. PubMed ID: 19254606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury.
    Logan WC; Sloane R; Lyles KW; Goldstein B; Hoenig HM
    Arch Phys Med Rehabil; 2008 Feb; 89(2):237-43. PubMed ID: 18226646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.